Dr. Adam Brufsky, MD
Claim this profileUniversity of Pittsburgh Cancer Institute (UPCI)
Expert in Breast Cancer
Expert in Breast cancer
31 reported clinical trials
70 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
Stage III
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Adam Brufsky, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Neratinib
for Breast Cancer
This phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers. Neratinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving neratinib in addition to normal therapy may work better in treating cancer than the endocrine therapy patients would normally receive.
Recruiting1 award Phase 2
More about Adam Brufsky, MD
Clinical Trial Related1 year of experience running clinical trials · Led 31 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Adam Brufsky, MD has experience with
- Paclitaxel
- Trastuzumab
- Abemaciclib
- Pertuzumab
- Olaparib
- Atezolizumab
Breakdown of trials Adam Brufsky, MD has run
Breast Cancer
Breast cancer
Skin Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Brufsky, MD specialize in?
Adam Brufsky, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Adam Brufsky, MD currently recruiting for clinical trials?
Yes, Adam Brufsky, MD is currently recruiting for 9 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Adam Brufsky, MD has studied deeply?
Yes, Adam Brufsky, MD has studied treatments such as Paclitaxel, Trastuzumab, Abemaciclib.
What is the best way to schedule an appointment with Adam Brufsky, MD?
Apply for one of the trials that Adam Brufsky, MD is conducting.
What is the office address of Adam Brufsky, MD?
The office of Adam Brufsky, MD is located at: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the University of Pittsburgh Cancer Institute (UPCI).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.